A. Sapino et al., Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast, J PATHOLOGY, 194(2), 2001, pp. 254-261
Citations number
39
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
CD31, an adhesion molecule expressed by endothelial cells, leukocytes, and
platelets, is used in surgical pathology as a marker of normal and neoplast
ic vascularization, During the assessment of angiogenesis in breast carcino
mas, CD31 expression was observed in a single case of large (5.2 cm diamete
r) high nuclear grade ductal carcinoma in situ (HG-DCIS) associated with po
orly differentiated invasive ductal carcinoma (G3-IDC), Expression was limi
ted to the cell membrane. This study focused on 32 HG-DCIS greater than or
equal to 2 cm, either pure or associated with IDC, Cancer cells were CD31() in 11 cases. Double staining using anti-CD31 monoclonal antibody (MAb) an
d anti-CD44 MAb, the anti-hyaluronate receptor, showed that foci of CD31(+)
and CD44(-) tumour cells could be traced throughout the glandular tree, ma
rking the intraductal diffusion of tumour up to Paget's cells at the nipple
, The associated G3-IDC and their lymph node metastases were instead CD31and CD44(+). CD31(+) tumours were oestrogen receptor (ER)(-), frequently p5
3(+) and c-erb-B2(+), and infiltrated by CD4(+) T lymphocytes, Normal and h
yperplastic epithelia were constantly CD31(-). Other endothelial markers (e
,g, Factor VIII-RA and CD34) were not expressed by carcinoma cells, as was
CD38, the CD31 ligand. In conclusion, CD31 expression is a feature acquired
by breast cancer cells in the DCIS model. CD31 expression mainly correlate
s with tumour cells spreading within the ductal system. Finally, the invasi
ve phenotype requires the co-expression of CD31 and CD44. Copyright (C) 200
1 John Wiley & Sons, Ltd.